Imran Mohd, Bakht Md Afroz, Khan Abida, Alam Md Tauquir, Anouar El Hassane, Alshammari Mohammed B, Ajmal Noushin, Vimal Archana, Kumar Awanish, Riadi Yassine
Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Northern Border University, Rafha 91911, Saudi Arabia.
Department of Chemistry, College of Science and Humanities in Al-Kharj, Prince Sattam Bin Abdulaziz University, Al-Kharj 11942, Saudi Arabia.
Molecules. 2020 Mar 2;25(5):1118. doi: 10.3390/molecules25051118.
We have developed a new idea to synthesize a key intermediate molecule by utilizing deep eutectic solvent (DES) and ultrasound in a multistep reaction to ensure process cost-effectiveness. To confirm the stability of reagents with DES, electronic energies were calculated at the B3LYP/6-31+G(d,p) level of theory. DES stabilized the reagents mainly due to strong intermolecular hydrogen bonding. Key intermediate (3) and final compounds (-) were synthesized in a higher yield of 95% and 80%-88%, respectively. Further, final compounds (-) were assessed for their anti-inflammatory, analgesic, ulcerogenic, and lipid peroxidation. The compounds , , , , and showed good anti-inflammatory activity, while , , and exhibited very good analgesic activity as compared to the standard drug. The ulcerogenicity of selected compounds was far less than the indomethacin. The ligands had also shown a good docking score ( = -6.859 kcal/mol and = -7.077 kcal/mol) as compared to control indomethacin (-6.109 kcal/mol) against the target protein COX-2. These derivatives have the potential to block this enzyme and can be used as NSAID. The state-of-art DFT theory was used to validate the lipid peroxidation mechanism of the active compounds which was in good agreement with the variations of BDEs and IP of the tested compounds.
我们提出了一种新的思路,即在多步反应中利用深共熔溶剂(DES)和超声来合成关键中间体分子,以确保工艺的成本效益。为了确认试剂与DES的稳定性,在B3LYP/6-31+G(d,p)理论水平上计算了电子能量。DES主要通过强分子间氢键使试剂稳定。关键中间体(3)和最终化合物(-)的合成产率分别较高,为95%和80%-88%。此外,对最终化合物(-)进行了抗炎、镇痛、致溃疡和脂质过氧化评估。化合物 、 、 、 和 表现出良好的抗炎活性,而 、 和 与标准药物相比表现出非常好的镇痛活性。所选化合物的致溃疡性远低于吲哚美辛。与对照吲哚美辛(-6.109 kcal/mol)相比,这些配体与靶蛋白COX-2的对接分数也很好( = -6.859 kcal/mol和 = -7.077 kcal/mol)。这些衍生物有可能阻断这种酶,可用作非甾体抗炎药。采用最先进的密度泛函理论(DFT)来验证活性化合物的脂质过氧化机制,该机制与测试化合物的键解离能(BDEs)和电离势(IP)的变化高度吻合。